AI Article Synopsis
- A female patient experienced neuroleptic malignant syndrome after taking both clozapine and haloperidol.
- After stopping clozapine suddenly, she had withdrawal symptoms.
- Psychiatrists may misdiagnose these withdrawal symptoms as worsening of the patient's original mental illness if they aren't aware of the potential effects of clozapine withdrawal.
Article Abstract
Here, we report a female patient developing neuroleptic malignant syndrome following the use of a combination of clozapine and haloperidol. Subsequently, the patient presented withdrawal effects after an abrupt discontinuation of clozapine. Psychiatrists not aware of possible clozapine-withdrawal effects may misdiagnose as a part of the primary mental illness or as the initial symptoms worsening, if unrecognized.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4820214 | PMC |
| http://dx.doi.org/10.2147/NDT.S103687 | DOI Listing |
Publication Analysis
Top Keywords
neuroleptic malignant
8
malignant syndrome
8
clozapine-withdrawal effects
8
syndrome subsequent
4
subsequent clozapine-withdrawal
4
effects patient
4
patient refractory
4
refractory schizophrenia
4
schizophrenia report
4
report female
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!